We first applied the γH2AX/CC3(bleb) assay to examine the induction of DNA damage response and apoptosis pathways following treatment with the genotoxic DNA topoisomerase I inhibitor topotecan in the A375 melanoma xenograft model (Figure 4A). This evidence concerns the gene TOP1 and melanoma.